A Study to Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating Anemia in Participants With Myelodysplastic Syndromes (MDS)

NCT07722988 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

201

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelodysplastic Syndromes

Interventions

DRUG: Roxadustat
DRUG: Placebo

Sponsor

Kyntra Bio